Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ADGI

Adagio Therapeutics (ADGI) Stock Price, News & Analysis

Adagio Therapeutics logo

About Adagio Therapeutics Stock (NASDAQ:ADGI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$3.40
$4.78
52-Week Range
N/A
Volume
22,357 shs
Average Volume
2.27 million shs
Market Capitalization
$504.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ADGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adagio Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ADGI Stock News Headlines

Our Favorite Advent Calendars
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.
See More Headlines

ADGI Stock Analysis - Frequently Asked Questions

Adagio Therapeutics, Inc. (NASDAQ:ADGI) posted its quarterly earnings data on Sunday, November, 14th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.74) by $0.24.

Adagio Therapeutics (ADGI) raised $301 million in an IPO on Friday, August 6th 2021. The company issued 17,700,000 shares at a price of $16.00-$18.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Adagio Therapeutics investors own include Meta Platforms (META), NVIDIA (NVDA), Pfizer (PFE), PayPal (PYPL), Tesla (TSLA), AbbVie (ABBV) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/14/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ADGI
CIK
1832038
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$226.79 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-57.14%
Return on Assets
-50.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.09
Quick Ratio
7.09

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
108,831,000
Free Float
N/A
Market Cap
$504.98 million
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:ADGI) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners